Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Bharglob 16.5% Injection

Bharglob 16.5% Injection is an immunoglobulin (Ig) therapy used to treat patients with primary and secondary immunodeficiencies and certain autoimmune inflammatory conditions. It contains Human Normal Immunoglobulin (16.5%), which supports the immune system by supplying essential antibodies that help fight infections and modulate immune responses.

In stock
SKU
SBBH05631
Price: 0.00 (Inclusive of Taxable Goods)
Bharglob 16.5% Injection is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Contains Human Normal Immunoglobulin for passive immunity

  • Used in both immunodeficiency and autoimmune conditions

  • Suitable for intravenous or subcutaneous administration

  • Produced from pooled human plasma

  • High purity and virus-inactivated for safety

  • Administered under medical supervision only

  • Offers both anti-infective and immunomodulatory benefits

Technical Details
Technical Specification
  • Brand Name: Bharglob 16.5%

  • Active Ingredient: Human Normal Immunoglobulin – 16.5% w/v

  • Form: Injectable solution

  • Route of Administration: Intravenous (IV) or Subcutaneous (SC)

  • Indications:

    • Primary and secondary immunodeficiencies

    • Primary immune thrombocytopenia

    • Guillain-Barré Syndrome

    • Kawasaki disease

    • CIDP (Chronic Inflammatory Demyelinating Polyneuropathy)

    • Multifocal motor neuropathy

  • Packaging: Glass vials in varying volumes (commonly 5 mL, 10 mL, 50 mL, etc.)

  • Storage Conditions: 2°C to 8°C (refrigeration required); do not freeze

  • 1 ml per vial
  • Boosts immune protection in patients with antibody deficiencies

  • Reduces frequency and severity of infections

  • Helps modulate autoimmune responses

  • Proven efficacy in neurological and vascular inflammatory diseases

  • Safe for pediatric, elderly, and immunocompromised patients when monitored

  • Reduces disease progression in CIDP and neuropathies

  • Can improve platelet counts in immune thrombocytopenia

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.